Description
BREO ELLIPTA FLUTICASONE-VILANTEROL
Asthma: RELVARE is indicated for the maintenance treatment of asthma.
COPD: RELVARE is indicated for the maintenance treatment of airway obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and / or emphysema, and to reduce COPD exacerbations in patients with a history of exacerbations.
BREO ELLIPTA FLUTICASONE-VILANTEROL
Reviews
There are no reviews yet.